- Home
- Equities - Stocks - Shares
- Company Press Releases
- Ultimovacs ASA: Invitation To Fourth Quarter 2024 Results Webcast Presentation
Ultimovacs ASA: Invitation to fourth quarter 2024 results webcast presentation
27 Jan 2025 08:47 CET
Issuer
Ultimovacs ASA
Oslo, January 27, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-
stage biotechnology company developing novel immunotherapies against cancer,
invites to a webcast presentation of its fourth quarter 2024 results, on Friday,
January 31, 2025.
The presentation can be followed as a live webcast accessed through a link on
www.ultimovacs.com at 09:00 CET on Friday, January 31, 2025. The webcast
presentation will be available on the Ultimovacs website, and it will be
possible to post questions during the presentation through the webcast. Note
that the webcast presentation has been rescheduled from February 13, 2025, due
to the ongoing business combination with Zelluna Immunotherapy AS, in order to
fulfill regulatory requirements associated with this process.
The report and presentation will be available on the company website from 07:00
CET the same day.
For further information, please see www.ultimovacs.com or contact:
Hans Vassgård Eid, CFO and Interim CEO, Ultimovacs ASA
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632
More information:
Access the news on Oslo Bors NewsWeb site
Source
Ultimovacs ASA
Provider
Oslo Børs Newspoint
Company Name
ULTIMOVACS
ISIN
NO0010851603
Symbol
ULTI
Market
Oslo Børs